SPORE in Prostate Cancer

  • Bergan, Raymond (PI)
  • Cella, David (PI)
  • Gann, Peter H. (PI)
  • Soff, Gerald (PI)
  • McVary, Kevin T. (PI)
  • Rademaker, Alfred (PI)
  • Kuzel, Timothy (PI)
  • Crawford, Susan (PI)
  • Jovanovic, Borko (PI)
  • Weichselbaum, Ralph (PI)
  • Chung, Lee (PI)
  • Wang, Zhou (PI)
  • Kaul, Karen (PI)
  • Catalona, William (PI)

Project: Research project

Description

DESCRIPTION(provided by applicant)
This SPORE application submitted in response to the RFA from the National
Cancer Institute, will take advantage of the strengths in prostate cancer
research and treatment that exist at the Robert H. Lurie Comprehensive Cancer
Center. The SPORE will provide the infrastructure to bring together basic
scientists and clinicians to rapidly test new approaches in the prevention,
early detection, diagnosis and treatment of human prostate cancer. The
specific themes of the SPORE are: 1. Cell and molecular biology of prostate cancer
2. Prevention and risk factors in prostate cancer development
3. Prostate cancer innovative therapeutics and rehabilitation
4. Quality of life and outcomes research in prostate cancer The SPORE application consists of six principal research projects, three
career development projects, five pilot projects and four Core facilities to
support the research. The principal research projects are: 1) Clusterin and
resistance to apoptosis (Lee), 2) Suppressive role of calreticulin in
prostate cancer (Wang), 3) Prostate cancer dependent generation of angiostatin
4.5 (Soff), 4) Molecular mechanisms of erectile dysfunction (McVary), 5)
Effects of lycopene on prostatic tissue (Gann), 6) Quality of life item
banking in prostate cancer (Cella). The Core facilities include:
Administration, Tissue Resource, Clinical and Biostatistical Cores. The
investigators selected to be part of the SPORE Program come from a variety of
disciplines ranging from Clinical Programs to Chemical Engineering, Pathology
and Chemistry. To maintain meaningful communication between investigators, we
will have monthly meetings of SPORE investigators, an annual retreat and
monthly meetings of the Executive Committee. Based on the infrastructure
described, our large patient population and our track record of productivity,
we believe that the Robert H. Lurie Comprehensive Cancer Center is well suited
for the SPORE program.
StatusFinished
Effective start/end date6/1/017/31/15

Funding

  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health

Fingerprint

Genistein
Cell Movement
Prostate
Prostatic Neoplasms
HSP27 Heat-Shock Proteins
Prostatectomy
Neoplasm Metastasis
Clinical Trials
Research
Phase II Clinical Trials
Clinical Trials, Phase I
Animal Models

ASJC

  • Medicine(all)